208 related articles for article (PubMed ID: 7581034)
1. Effect of manipulation of the GABA system on dopamine-related behaviors.
Sandoval MR; Palermo-Neto J
Braz J Med Biol Res; 1995 Jan; 28(1):88-99. PubMed ID: 7581034
[TBL] [Abstract][Full Text] [Related]
2. Behavioral aspects of GABAergic-dopaminergic interactions in the central nervous system.
Sandoval MR; Palermo-Neto J
Eur J Pharmacol; 1989 Aug; 167(1):117-25. PubMed ID: 2776839
[TBL] [Abstract][Full Text] [Related]
3. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
Markovska V; Georgiev V
Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
[TBL] [Abstract][Full Text] [Related]
4. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
Flório JC; Palermo-Neto J
Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
Minematsu N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
[TBL] [Abstract][Full Text] [Related]
6. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
Surmann A; Havemann-Reinecke U
J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
[TBL] [Abstract][Full Text] [Related]
7. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
8. Alterations in apomorphine concentration in spinal cord and brain follow the time course of catalepsies induced by different treatments.
Kolasiewicz W; Harasiewicz A; Melzacka M; Wolfarth S
Exp Neurol; 1983 Jul; 81(1):195-209. PubMed ID: 6861947
[TBL] [Abstract][Full Text] [Related]
9. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
Balsara JJ; Bapat TR; Chandorkar AG
Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
[TBL] [Abstract][Full Text] [Related]
10. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
[TBL] [Abstract][Full Text] [Related]
11. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
12. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712
[TBL] [Abstract][Full Text] [Related]
13. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
Lipska BK; Weinberger DR
Brain Res Dev Brain Res; 1993 Oct; 75(2):213-22. PubMed ID: 7903225
[TBL] [Abstract][Full Text] [Related]
14. Lack of the effect of ketamine on some dopaminergic behaviors in rats.
Morato GS; Takahashi RN
Braz J Med Biol Res; 1986; 19(3):403-9. PubMed ID: 3594006
[TBL] [Abstract][Full Text] [Related]
15. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
16. Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1988; 14(2):56-62. PubMed ID: 2851915
[TBL] [Abstract][Full Text] [Related]
17. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
18. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
Amabeoku GJ
Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
[TBL] [Abstract][Full Text] [Related]
19. Effects of buspirone on dopaminergic supersensitivity.
Queiroz CM; Frussa-Filho R
Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
[TBL] [Abstract][Full Text] [Related]
20. Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
Owolabi AR; Akanmu MA; Ukponmwan OE
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):117-24. PubMed ID: 18408917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
